Posted on 1/9/18
Precision For Medicine Expands Services In Europe
Precision for Medicine, part of Precision Medicine Group, today announced it is expanding its biomarker data management and translational informatics services into Europe. The addition of . . .
Posted on 1/8/18
Merkle Named First Agency Global Specialized Partner for Adobe Campaign
COLUMBIA, Md.--(BUSINESS WIRE)--Merkle (www.merkleinc.com), a leading technology-enabled, data-driven performance marketing agency, announced that it has been awarded the Global Specialized Partner status for Adobe Campaign, part . . .
Posted on 1/4/18
Personal Genome Diagnostics Raises $75 Million
Personal Genome Diagnostics Inc. (PGDx) today announced a $75 million Series B financing co-led by new investor Bristol-Myers Squibb and existing investor
Posted on 1/4/18
3 Biotech Stocks to Buy in January
Biotechnology stocks performed exceptionally well last year, and this positive trend appears set to continue in 2018. As such, investors may want to kick off the . . .
Posted on 1/3/18
Corsair Pharma and United Therapeutics Enter into Strategic Collaboration
United Therapeutics Corporation (NASDAQ: UTHR), a leading biotechnology company focused on development of therapies for the treatment of pulmonary arterial hypertension (PAH), and Corsair Pharma, Inc., . . .
Posted on 1/2/18
Inspire Continues Expansion of Partnerships with Nonprofit Advocacy Organizations
ARLINGTON, Va., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Inspire, the leading healthcare social network, has expanded its reach with new partnerships with nonprofit patient advocacy organizations. . . .
Posted on 12/29/17
Sucampo Pharmaceuticals: What Can Investors Learn From The Mallinckrodt Acquisition?
Mallinckrodt to acquire Sucampo Pharmaceuticals for $1.2B. The cash tender offer equates to $18 per share.Mallinckrodt to take ownership of Amitiza, a leading medicine servicing the . . .
Posted on 12/27/17
American Kidney Fund Earns 16th Consecutive 4-star Rating From Charity Navigator
The American Kidney Fund's (AKF) strong financial health and commitment to accountability and transparency have again earned it the highest, 4-star rating from Charity Navigator, America's . . .
Posted on 12/21/17
Lab Tests Online Redesigns Website
Lab Tests Online, AACC's award-winning public resource on laboratory testing, is pleased to announce that it has launched a dynamic redesign of labtestsonline.org to better help . . .
Posted on 12/21/17
Medifast to Participate in the 20th Annual ICR Conference
Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven healthy living products and programs, announced today that Daniel R. Chard, Chief Executive Officer, . . .
Posted on 12/25/17
Just in Time for New Year’s Day Hangovers, The I.V. Doc Opens in Washington
Concierge I.V. hydration therapy will have you feeling good as new in minutes.The throbbing headache. The queasy stomach. The dry mouth. If you’re dreading the thought . . .
Posted on 12/20/17
ClearPath Development Company Launches Third Collaboration Under Strategic Partnership With Astellas Pharma
ClearPath Development Company (ClearPath) announced today it has initiated a third research collaboration with Astellas Pharma Inc. to combat infections. The new collaboration, executed by a . . .
Posted on 12/20/17
NW Bio Announces Regulation D Offering for Accredited Investors
Northwest Biotherapeutics (OTCQB: NWBO) -- (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that it is commencing a . . .
Posted on 1/16/18
Foundation Fighting Blindness Celebrates Historic FDA Approval of First Gene Therapy
Today's U.S. Food and Drug Administration (FDA) approval of voretigene neparvovec, to be marketed as LUXTURNA™, will be life-changing for patients with vision loss due to . . .
Posted on 12/18/17
The Carlyle Group, Along with Management and Level Equity, To Acquire Net Health
Net Health, a provider of cloud-based clinical documentation, practice management, and billing solutions for specialized outpatient healthcare providers
Posted on 12/16/17
GlycoMimetics Added To NASDAQ Biotechnology Index
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (NASDAQ: GLYC) today announced that it will be included in the NASDAQ Biotechnology Index® (NBI). The annual re-ranking of the NASDAQ Biotechnology . . .
Posted on 12/12/17
American Gene Technologies Receives U.S. Patent on Novel Immuno-Oncology Methods of Treating Cancer
American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced the issuance of U.S. Patent No: 9,834,790 dated December 5, 2017, . . .
Posted on 12/11/17
Processa Pharmaceuticals Announces Reverse Stock Split and Launches New Website
Processa Pharmaceuticals, Inc., formed from the merger of Promet Therapeutics and Heatwurx Inc., is an emerging clinical stage biotech company focused on the development of drugs for . . .
Posted on 12/11/17
Intercell USA Changes Name to Valneva USA
GAITHERSBURG, Md.--(BUSINESS WIRE)--Valneva SE, a fully integrated commercial stage biotech company focused on developing innovative, lifesaving vaccines, today announced that its subsidiary Intercell USA, Inc. has . . .
Posted on 12/10/17
Handcrafted Bracelet Collection Launched To Benefit NKF Serving Maryland and Delaware
LUTHERVILLE, Md. (Dec. 11, 2017) – Combining style with philanthropy, the Knock Out Kidney Disease (KOKD) collection of bracelets with “purpose-filled” trinkets is available for purchase to . . .
Posted on 12/8/17
Osiris Therapeutics: Expecting Better In 2018
What Is Osiris Therapeutics?Osiris Therapeutics (NASDAQ:OSIR) spun out of Case Western Reserve University in 1992 to leverage stem cell technology discovered by Dr. Arnold Caplan and . . .
Posted on 12/8/17
Children's National Health System Named Leapfrog Group's "Top Hospital"
Children's National Health System has been named a Leapfrog Group Top Hospital for 2017; one of only 10 children's hospitals in the United Statesand the only . . .
Posted on 12/8/17
RegeneRx Releases Annual Letter to Shareholders
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that its year end letter to shareholders. . . .
Posted on 12/7/17
Ciena Announces $300 Million Share Repurchase Authorization
HANOVER, Md.--(BUSINESS WIRE)--Ciena (NYSE: CIEN), a network strategy and technology company, today announced that its Board of Directors has authorized a program to repurchase up to $300 . . .
Posted on 12/6/17
MacroGenics Closes MGA012 Global Collaboration and License Agreement with Incyte
ROCKVILLE, MD, Dec. 05, 2017 (GLOBE NEWSWIRE) --MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment . . .
Washington DC
